Richard E. Kuntz, M.D.

Richard E. Kuntz, M.D.

DirectoratMedtronic· In proxies 2021–2024

Pay in FY2021

Richard E. Kuntz, M.D. was paid $6.4M in FY2021 (Apr).

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Medtronic proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. INVE TechnologiesPublic company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  2. MedtronicPublic company · 5 yr
    • 2021 – Present · 5 yrNo stock prices for these years
  3. Endospan Ltd.Public company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  4. DiaMedica Therapeutics, Inc.Public company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  5. Bactiguard Holding ABPublic company · 4 yr
    • Director2022 – Present · 4 yrNo stock prices for these years
  6. Cognito Therapeutics Inc.Public company · 4 yr
    • Director2022 – Present · 4 yrNo stock prices for these years
  7. Rockley Photonics Holdings LtdPublic company · 4 yr
    • Director2022 – Present · 4 yrNo stock prices for these years
  8. ZimVie Inc.Public company · 4 yr
    • Director2022 – Present · 4 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • INVE TechnologiesDirector · 2 yr on the boardIndependentCompensation, Nominating (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?